Ji-bin Y. Li
651, Dong Feng Dong Lu Road
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 117 publications
Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma: The Phase 3 TORCH Randomized Clinical Trial.
Journal: JAMA oncology
Published: July 30, 2026
Clinical study on liquid-phase concentrated growth factor combined with low-level laser therapy for improving gingival papilla regeneration through microtrauma healing mechanisms
Journal: Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
Published: June 01, 2026
Perioperative Toripalimab Plus Chemotherapy Versus Chemotherapy Alone in Locally Advanced Gastric or Gastroesophageal Junction Cancer: 3-Year Follow-Up of NEOSUMMIT-01 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 05, 2026
Medial retropharyngeal nodal region sparing radiotherapy in nasopharyngeal carcinoma: five year analysis of open label, non-inferiority, multicentre, randomised phase 3 trial.
Journal: BMJ (Clinical research ed.)
Published: March 31, 2026
Average and Heterogeneous Associations between Secondhand Smoking and Tooth Loss.
Journal: Journal of dental research
Published: March 09, 2026
TQB2618 plus Penpulimab, Alone or in Combination with Chemotherapy, for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter, Two-Cohort, Phase II Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 25, 2026
Toripalimab-Based Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma-Reply.
Journal: JAMA
Published: December 08, 2025
Long-Term Outcomes of Reduced-Dose Radiation Therapy in Patients with Epstein-Barr Virus DNA-Selected Stage III Nasopharyngeal Carcinoma: A 5-Year Follow-Up Secondary Analysis of a Phase II Trial.
Journal: International journal of radiation oncology, biology, physics
Published: December 01, 2025
Concurrent chemoradiotherapy plus nimotuzumab versus chemoradiotherapy alone for locoregionally advanced nasopharyngeal carcinoma with a suboptimal response to induction chemotherapy: a randomized phase 2 trial.
Journal: Nature communications
Published: October 15, 2025
Patient-reported outcomes from a phase 2 PLATINUM trial of nivolumab combination therapy sparing concurrent cisplatin in nasopharyngeal carcinoma.
Journal: Med (New York, N.Y.)
Published: October 03, 2025
Stereotactic body radiotherapy plus sunitinib vs. sunitinib alone in treatment-naive oligometastatic renal cell carcinoma: A phase 2 clinical trial.
Journal: Cell reports. Medicine
Published: September 24, 2025
Last Updated: 09/26/2026